Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 1
Sponsor overview
Heidelberg Pharma AG
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT01581060
Assets
Linked programs
- WX-554: Registry Stop Signal (4/5)